IP Verse

Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production

Patent No. EP3581650 (titled "Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production") was filed by Uniqure Biopharma on Sep 15, 2009. The application was issued on Dec 28, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
PFIZERSep 27, 2023PFIZER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3581650

UNIQURE BIOPHARMA
Application Number
EP19174517A
Filing Date
Sep 15, 2009
Status
Granted And Under Opposition
Nov 25, 2022
Publication Date
Dec 28, 2022
External Links
Slate, Register , Google Patents